Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model

Immunology Letters

Volumn 135, Issue 1-2, 2011, Pages 144-150

  Yamamoto, Aihiro ^a   Ashihara, Eishi ^b   Nakagawa, Yoko ^b   Obayashi, Hiroshi ^c   Ohta, Mitsuhiro ^d   Hara, Hirokazu ^e   Adachi, Tetsuo ^e   Seno, Takahiro ^a   Kadoya, Masatoshi ^a   Hamaguchi, Masahide ^a   Ishino, Hidetaka ^a   Kohno, Masataka ^a   Maekawa, Taira ^b   Kawahito, Yutaka ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c Institute of Bio Response Informatics   (Japan)

^d KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^e GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Allograft inflammatory factor 1 (AIF 1); Fibroblast; GVHD; Migration; Scleroderma

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST CULTURE; GENE OVEREXPRESSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCLERODERMA; SKIN FIBROBLAST; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CHEMOTAXIS; DERMIS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; RATS; SCLERODERMA, SYSTEMIC; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 78751701215     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.10.015     Document Type: Article

References (41)

1. Iris F.J., Bougueleret L., Prieur S., Caterina D., Primas G., Perrot V., et al. Dense Alu clustering and a potential new member of the NFB family within a 90 kilobase HLA class III segment. Nat Genet 1999, 3:137-145.
2. Autieri M.V. cDNA cloning of human allograft inflammatory factor-1: tissues distribution, cytokine induction, and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 1996, 228:329-376.
3. Utans U., Arceci R.J., Yamashita Y., Russell M.E. Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 1995, 95:2954-2962.
4. Utans U., Quist W.C., McManus B.M., Wilson J.E., Arceci R.J., Wallace A.F., et al. Allograft inflammatory factor-1: a cytokine-responsive macrophage molecule expressed in transplanted human heart. Transplantation 1996, 61:1387-1392.
5. Hara H., Ohta M., Ohta K., Nishimura M., Obayashi H., Adachi T. Isolation of two novel alternative splicing variants of allograft inflammatory factor-1. Biol Chem 1999, 380:1333-1336.
6. Kimura M., Kawahito Y., Obayashi H., Ohta M., Hara H., Adachi T., et al. A critical role for allograft inflammatory factor-1 in the pathogenesis of rheumatoid arthritis. J Immunol 2007, 178:3316-3322.
7. Del Galdo F., Maul G.G., Jimenez S.A., Artlett C.M. Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor-β. Arthritis Rheum 2006, 54:2616-2625.
8. Otieno F.G., Lopez A.M., Jimenez S.A., Gentiletti J., Artlett C.M. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis. Tissue Antigens 2007, 69:583-591.
9. Pawlik A., Kurzawski M., Szczepanik T., Dziedziejko V., Safranow K., Borowiec-Chłopek Z., et al. Association of allograft inflammatory factor-1 gene polymorphism with rheumatoid arthritis. Tissue Antigens 2008, 72:171-175.
10. Alkassab F., Gourh P., Tan F.K., McNearney T., Fischbach M., Ahn C., et al. An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) 2007, 46:1248-1251.
11. Takehara K. Pathogenesis of systemic sclerosis. J Rheumatol 2003, 30:755-759.
12. Duncan M.R., Frazier K.S., Abramson S., Williams S., Klapper H., Huang X., et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 1999, 13:1774-1786.
13. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Grotendorst G.R., et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995, 105:280-284.
14. Kelemen S.E., Autieri M.V. Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am J Pathol 2005, 167:619-626.
15. Del Galdo F., Jiménez S.A. T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro. Arthritis Rheum 2007, 56:3478-3488.
16. Orsmark C., Skoog T., Jeskanen L., Kere J., Saarialho-Kere U. Expression of allograft inflammatory factor-1 in inflammatory skin disorders. Acta Derm Venereol 2007, 87:223-227.
17. Tian Y., Jain S., Kelemen S.E., Autieri M.V. AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis. Am J Physiol Cell Physiol 2009, 296:256-266.
18. Furst D.E., Clements P.J., Graze P., Gale R., Roberts N. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?. Arthritis Rheum 1979, 22:904-910.
19. Zhang Y., McCormick L.L., Desai S.R., Wu C., Gilliam A.C. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088-3098.
20. Rogai V., Lories R.J., Guiducci S., Luyten F.P., Matucci-Cerinic M. Animal models in systemic sclerosis. Clin Exp Rheumatol 2002, 26:941-946.
21. McCormick L.L., Zhang Y., Tootell E., Gilliam A.C. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999, 163:5693-5699.
22. Nagira T., Matthew S.B., Yamakoshi Y., Tsuchiya T. Enhancement of gap junctional intercellular communication of normal human dermal fibroblasts cultured on polystyrene dishes grafted with poly-N-isopropylacrylamide. Tissue Eng 2005, 11:1392-1397.
23. Kawata E., Ashihara E., Kimura S., Takenaka K., Sato K., Tanaka R., et al. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Mol Cancer Ther 2008, 7:2904-2912.
24. Deininger M.H., Meyermann R., Schluesener H.J. The allograft inflammatory factor-1 family of proteins. FEBS Lett 2002, 514:115-121.
25. Yamada R., Sano H., Hla T., Hashiramoto A., Fukui W., Miyazaki S., et al. Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes. Eur J Pharmacol 1999, 385:71-79.
26. Furuya M., Kato H., Nishimura N., Ishiwata I., Ikeda H., Ito R., et al. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets. Cancer Res 2006, 5:2617-2625.
27. Kikuchi Y., Takai T., Ota M., Kato T., Takeda K., Mitsuishi K., et al. Application of immunoreaction enhancer solutions to an enzyme-linked immunosorbent assay for antigen-specific IgE in mice immunized with recombinant major mite allergens or ovalbumin. Int Arch Allergy Immunol 2006, 141:322-330.
28. Uchida H., Maruyama T., Ono M., Ohta K., Kajitani T., Masuda H., et al. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 2007, 148:896-902.
29. Distler J.H., Akhmetshina A., Schett G., Distler O. Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis. Rheumatology 2009, 48:98-103.
30. Mehrad B., Burdick M.D., Strieter R.M. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 2009, 41:1708-1718.
31. Lama V.N., Phan S.H. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006, 3:373-376.
32. Lin W.R., Brittan M., Alison M.R. The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 2008, 188:178-188.
33. Strieter R.M., Gomperts B.N., Keane M.P. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 2007, 117:549-556.
34. Chen X., Kelemen S.E., Autieri M.V. AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol 2004, 24:1217-1222.
35. Autieri M.V., Carbone C. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler Thromb Vasc Biol 2000, 20:1737-1744.
36. Kishimoto T. The biology of interleukin-6. Blood 1989, 74:1-10.
37. Feghali C.A., Bost K.L., Boulware D.W., Levy L.S. Mechanisms of pathogenesis in scleroderma I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol 1992, 19:1207-1211.
38. Hasegawa M., Sato S., Fujimoto M., Ihn H., Kikuchi K., Takehara K. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J Rheumatol 1998, 25:308-313.
39. Duncan M.R., Berman B. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991, 97:686-692.
40. Kurasawa K., Hirose K., Sano H., Endo H., Shinkai H., Nawata Y., et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 2000, 43:2455-2463.
41. Murata M., Fujimoto M., Matsushita T., Hamaguchi Y., Hasegawa M., Takehara K., et al. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?. J Dermatol Sci 2008, 50:240-242.